COVID Protection After Transplant Pilot Study - NCT04969263

Proportion of participants who have a protective antibody response to the mRNA-based COVID-19 vaccine, Frequency of solicited local reactogenicity adverse events (AEs) to the mRNA-based COVID-19 vaccine, Frequency of solicited local allergic reaction adverse events (AEs) to the mRNA-based COVID-19 vaccine, (and 9 more...)